Invasive aspergillosis caused by Aspergillus ustus: Case report and review

Journal of Clinical Microbiology

Volumn 37, Issue 5, 1999, Pages 1606-1609

  Verweij, Paul E ^a   Van Den Bergh, Marjolein F Q ^a   Rath, Peter M ^b   De Pauw, Ben E ^a   Voss, Andreas ^a   Meis, Jacques F G M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ITRACONAZOLE; TERBINAFINE; VORICONAZOLE;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIGEN DETECTION; ARTICLE; ASPERGILLUS; ASPERGILLUS USTUS; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; DRUG SENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNGICIDAL ACTIVITY; FUNGUS IDENTIFICATION; HOSPITAL INFECTION; HUMAN; LUNG ASPERGILLOSIS; MALE; PRIORITY JOURNAL;

ASPERGILLUS USTUS; FUNGI;

EID: 0032895060     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.5.1606-1609.1999     Document Type: Article

References (26)

1. Bretagne, S., A. Marmorat-Khuong, M. Kuentz, J. P. Latgé, E. Bart-Delabesse, and C. Cordonnier. 1997. Serum Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients. J. Infect. 35:7-15.
2. Carrizosa, J., M. E. Levison, T. Lawrence, and D. Kaye. 1974. Cure of Aspergillus ustus endocarditis on a prosthetic valve. Arch. Intern. Med. 133: 486-490.
3. Denning, D. W., A. del Favero, E. Gluckman, D. Norfolk, M. Rhunke, S. Yonren, P. Troke, and N. Sarantis. 1996. UK-109,496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: clinical efficacy in acute invasive aspergillosis, abstr. F80, p. 126. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
4. Denning, D. W., K. Venkateswarlu, K. L. Oakley, M. J. Anderson, N. J. Nanning, D. A. Stevens, D. W. Warnock, and S. L. Kelly. 1997. Itraconazole resistance in Aspergillus fumigatus. Antimicrob. Agents Chemother. 41:1364-1368.
5. De Sévaux, R. G. L., B. J. Kullberg, P. E. Verweij, J. A. P. Van De Nes, J. Festen, J. F. G. M. Meis, and J. W. M. Van Der Meer. 1998. Microgranulomatous aspergillosis in a patient with chronic granulomatous disease: cure with voriconazole. Clin. Infect. Dis. 26:996-997.
6. Dickinson, R. P. A. S. Bell, C. A. Hitchcock, S. Narayanaswami, S. J. Ray, K. Richardson, and P. F. Troke. 1996. Novel antifungal 2-aryl-1-(1H-1,2,4-triazol-1-YL)butan-2-OL derivates with high activity against Aspergillus fumigatus. Bioorg. Med. Chem. Lett. 16:2031-2036.
7. Hospenthal, D. R., K. J. Kwon-Chung, and J. E. Bennett. 1998. Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation. Med. Mycol. 36:165-168.
8. Iwen, P. C., M. E. Rupp, A. N. Langnas, R. C. Reed, and S. H. Hinrichs. 1998. Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature. Clin. Infect. Dis. 26:1092-1097.
9. Iwen, P. C., M. E. Rupp, M. R. Bishop, M. G. Rinaldi, D. A. Sutton, S. Tarantolo, and S. H. Hinrichs. 1998. Disseminated aspergillosis caused by Aspergillus ustus in a patient following allogeneic peripheral stern cell transplantation. J. Clin. Microbiol. 36:3713-3717.
10. Luce, J. M., R. C. Ostenson, S. C. Springmeyer, and L. D. Hudson. 1979. Invasive aspergillosis presenting as pericarditis and cardiac tamponade. Chest 76:703-705.
11. Mitchell, S. J., J. Gray, M. E. Morgan, M. D. Hocking, and G. M. Durbin. 1996. Nosocomial infection with Rhizopus microsporus in preterm infants: association with wooden tongue depressors. Lancet 348:441-443.
12. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
13. Nolard, N. Personal communication.
14. Oakley, K. L., C. B. Moore, and D. W. Denning. 1998. In-vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin B. J. Antimicrob. Chemother. 42:91-94.
15. Ricci, R. M., J. S. Evans, J. J. Meffert, L. Kaufman, and L. C. Sadkowski. 1998. Primary cutaneous Aspergillus ustus infection: second reported case. J. Am. Acad. Dermatol. 38:797-798.
16. Sandner, V. K., and C. Schönborn. 1973. Schimmelpilzinfektion der Haut bei ausgedektner Verbrennung. Deutsch. Ges.-Wesen 28:125-128.
17. Schmitt, H. J., E. M. Bernard, J. Andrade, F. Edwards, B. Schmitt, and D. Armstrong. 1988. MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp. Antimicrob. Agents. Chemother. 32:780-781.
18. Stiller, M. J., L. Teperman, S. A. Rosenthal, A. Riordan, J. Potter, J. L. Shupack, and M. A. Gordon. 1994. Primary cutaneous infection by Aspergillus ustus in a 62-year-old liver transplant recipient. J. Am. Acad. Dermatol. 31:344-347.
19. Stynen, D., A. Goris, J. Sarfati, and J. P. Latgé. 1995. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J. Clin. Microbiol. 33:497-500.
20. Swanink, C. M. A., J. F. G. M. Meis, A. J. M. M. Rijs, J. P. Donnelly, and P. E. Verweij. 1997. Specificity of an enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J. Clin. Microbiol. 35:257-260.
21. Van't Hek, L. G., P. E. Verweij, C. M. Weemaes, R. Van Dalen, J. B. Yntema, and J. F. G. M. Meis. 1998. Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease. Am. J. Respir. Crit. Care Med. 157:1694-1696.
22. Verweij, P. E., K. L. Oakley, J. Morrisey, G. Morrisey, and D. W. Denning. 1998. In vivo activity of LY 303366 against amphotericin B-susceptible and -resistant Aspergillus fumigatus in a murine model of invasive aspergillosis. Antimicrob. Agents Chemother. 42:873-878.
23. Verweij, P. E., D. Poulain, T. Obayashi, T. F. Patterson, D. W. Denning, and J. Ponton. 1998. Current trends in the detection of antigenemia, metabolites and cell wall markers for the diagnosis and therapeutic monitoring of fungal infections. Med. Mycol. 36(Suppl. I):146-155.
24. Verweij, P. E., A. J. M. M. Rijs, B. E. De Pauw, A. M. Horrevorts, J. A. A. Hoogkamp-Korstanje, and J. F. G. M. Meis. 1995. Clinical evaluation and reproducibility of the Pastorex Aspergillus antigen latex agglutination test for diagnosing invasive aspergillosis. J. Clin. Pathol. 48:474-176.
25. Wald, A., W. Leisenring, J. A. van Bunk, and R. A. Bowden. 1997. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J. Infect. Dis. 175:1459-1466.
26. Weiss, L. M., and W. A. Thiemke. 1983. Disseminated Aspergillus ustus infection following cardiac surgery. Am. J. Clin. Pathol. 80:408-411.